7:00 | 05.05.2021
DSM provides Q1 2021 trading update

HEERLEN, Netherlands, May 5, 2021 /PRNewswire/ – [ ]Highlights(1)
— DSM delivered a very good first quarter
— Group sales +7% and Adjusted EBITDA +13%

— Nutrition: sales +7%, organic sales +7%, Adjusted EBITDA +9%
— Materials: sales +13%, volumes +21%, Adjusted EBITDA +27%
— Outlook 2021: Group Outlook updated to reflect stronger Materials
Key figures – continuing operations(2)

in EUR million Q1 2021
Q1 2020
% Change

Sales 2,194 2,045 7% 9% -1% -6% 5%

Nutrition 1,678 1,575 7% 7% 0% -6% 6%

Materials 467 413 13% 21% -4% -4% 0%

Adjusted EBITDA 441 390 13%

Nutrition 352 324 9%

Materials 108 85 27%

Innovation 6 5

Corporate -25 -24

EBITDA 425 326

Adjusted EBITDA margin 20.1% 19.1%

(1) Adjusted EBITDA is an
Alternative Performance Measure
(APM) that reflects results
from usual operations. Organic
sales growth is the total
impact of volume and price/
mix. Adjusted Net Operating
Free Cash Flow is the cash flow
from operating activities,
corrected for the cash flow of
the APM adjustments, minus the
cash flow of capital
expenditures and drawing

(2) Results and KPIs throughout
this document reflect continued
operations, excluding the
Resins & Functional Materials
and associated businesses which
were classified as ‘held for
sale’ in September 2020. The
sale was finalized on 1 April
Co-CEOs statement
Geraldine Matchett and Dimitri de Vreeze, Co-CEOs, commented: “We made a very good start to the year despite the ongoing challenging COVID-19 environment. Our Nutrition business continued to perform well, with positive momentum in line with the trading conditions we saw during the second half of 2020. The strong recovery of our Materials business at the end of last year has continued into Q1, supported by ongoing restocking by customers. Our increasing confidence in the recovery for Materials, combined with our unchanged positive outlook for Nutrition, leads us to increase our overall outlook for the Group for 2021.”Outlook 2021
For the full year, DSM continues to expect an Adjusted EBITDA increase in Nutrition at the upper end of its mid-term strategic ambition of high single digit growth. Together with a stronger recovery in Materials than foreseen at the FY 2020 results release, DSM now expects an Adjusted EBITDA growth rate for the Group moving towards the mid-teens, with a continued good Adjusted Net Operating Free Cash Flow.Note for the editors: for the full text of the press release see enclosed pdf or click here []>Financial calendar

6 May 2021 Annual General Meeting of

3 August 2021 Publication of the half year
results of 2021

2 November 2021 Trading update for the first nine
months of 2021
Contact Information
Investor Relations
Dave Huizing

t. +31 (0) 45 578 2864


Media Relations
Lieke de Jong

t. +31 (0) 45 578 2420

Additional Information
Starting in 2021, DSM changed its reporting cycle, in line with the established practice of many of its consumer ingredients peers. From Q1 2021, DSM will provide a trading update for Q1 and Q3. DSM will organize media and analyst calls during half year and full year.DSM – Bright Science. Brighter Living.(TM)
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about EUR10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at [].Find us on:
Facebook: []
Twitter: []
LinkedIn: []
YouTube: []Forward Looking Statements
This press release may contain forward-looking statements with respect to DSM’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.Logo – []Photo: DSM

Web site:


Abonnieren Sie jetzt unsere
- Daily
- Weekly


09:04 Uhr | 19.04.2021
Ifo: Corona trifft Städte ...

08:57 Uhr | 19.04.2021
Kreise: Söder nach Treffen mit ...

08:52 Uhr | 19.04.2021
AKTIE IM FOKUS: Eon nach ...

08:52 Uhr | 19.04.2021
Sitzung des UEFA-Exekutivkomitees ...

08:49 Uhr | 19.04.2021
Aktien Asien: China-Börsen klar ...